LP
MD icon

Longview Partners’s Pediatrix Medical MD Stock Holding History

Longview Partners’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,491,731
Closed -$107M – 24
2017
Q3 		$107M Sell
2,491,731
-2,531,745
-50% -$120M 0.58% 24
2017
Q2 		$303M Buy
5,023,476
+467,845
+10% +$27.7M 1.75% 24
2017
Q1 		$316M Buy
4,555,631
+980,081
+27% +$68.1M 2.06% 24
2016
Q4 		$238M Buy
+3,575,550
New +$233M 1.58% 23

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Longview Partners's MD Position: Q4 2017 in Review

Longview Partners sold out of Pediatrix Medical (MD) in Q4 2017, closing a stake of 2,491,731 shares — an estimated $107M sold.

Longview Partners first reported a position in MD in Q4 2016 and held it in 4 quarters. The position peaked at $316M in Q1 2017. 330 funds tracked by Wall St. Rank hold MD as of Q4 2017.

  • Longview Partners reported no remaining Pediatrix Medical position as of Q4 2017 after selling out during the quarter.
  • Longview Partners sold 2,491,731 Pediatrix Medical shares in Q4 2017, an estimated $107M.
  • Longview Partners first reported a position in Pediatrix Medical in Q4 2016 and held it in 4 quarters.
  • Longview Partners's Pediatrix Medical position peaked at $316M in Q1 2017.
  • 330 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2017.

Based on Longview Partners's 13F filing for Q4 2017, filed 6 Feb 2018.